IFRX

InflaRx N.V.

Price

$2.08

return (12m)

54.85%

p/e

-4.08

p/bv

1.45

DIVIDEND YIELD

0.00%

IFRX price

InflaRx

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment IFRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-1.19%

3 months

14.64%

1 year

54.85%

2 years

36.51%

5 years

-24.55%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals IFRX

Valuation

P/E

-4.08

Sector -3.50

Industry -3.50

P/BV

1.45

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector 2.01

Industry 2.01

EV/EBITDA

-5.15

Sector -214.99

Industry -214.99

EV/EBIT

-5.10

Sector -47.59

Industry -47.59

P/EBITDA

-5.44

Sector -21.41

Industry -21.41

P/EBIT

-5.39

Sector -28.65

Industry -28.65

P/Total Assets

1.27

Sector 1.19

Industry 1.19

P/Net Current Assets

1.47

Sector -11.97

Industry -11.97

P/Working Capital

1.46

Sector -167.95

Industry -167.95

EPS

-0.51

Sector -1.81

Industry -1.81

BVPS

1.43

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

-100.00%

Sector 41.30%

Industry 41.30%

EBITDA Margin

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-100.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-100.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.00

Sector 0.02

Industry 0.02

Profitability

ROE

-35.60%

Sector -56.04%

Industry -56.04%

ROA

-31.18%

Sector -60.31%

Industry -60.31%

ROIC

-233.16%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

8.22

Sector 2.89

Industry 2.89

Net Debt / EBITDA

15.11

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

14.97

Sector -8.06

Industry -8.06

Net Debt / Equity

-1.08

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.88

Sector 0.46

Industry 0.46

Liabilities/Assets

0.12

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

2.27%

Sector -

Industry -

Fundamentals IFRX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
IFRX InflaRx N.V.	$2.08	75.85%	0.00%	-4.08	1.45	-35.60%	-100.00%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.14%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	43.77%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.89%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

IFRX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT InflaRx

InflaRx N.V.

Average Investor10 user rating

4.0 (2 people)

United States

19 years

Founded: 2007

2017

Time since IPO - 9 years

49

Employees

InflaRx N.V. (United States) is listed on the Nasdaq and has a market capitalization of $244.85 million, with shareholders equity totaling $168.41 million.

The company employs approximately 49 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, InflaRx N.V. reported $18.00 Thousand in revenue, generating net income of $-59.95 million.

Key financial metrics include a P/E ratio of -4.08, a price-to-book (P/B) ratio of 1.45, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker IFRX.

Market cap

$244.85 million

Net worth

$168.41 million

$168,410,000.00

Assets

$192.29 million

$192,290,000.00

Total Shares Outstanding

118.00 million

118,000,000

Average Daily Trading Volume

$878.34 Thousand

$878,337.90

Sector

Health Care

Industry

Biotechnology

IFRX

IFRX revenue and profits

Financial Results IFRX

DRAG THE FRAME TO SEE MORE DATA

IFRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,76% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$224.45 51,61% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 85,19% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,76% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$224.45 51,61% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 85,19% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of InflaRx (IFRX) today?

A cotação de InflaRx (IFRX) hoje está em US$ 2.08, com uma variação de 54.85% em relação ao último ano. A cotação de InflaRx (IFRX) iniciou o ano negociando na casa dos US$ 1.01 e hoje está em US$ 2.08. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de InflaRx (IFRX) e dados de ações do Ibovespa e mercados internacionais.

Quando InflaRx (IFRX) paga dividendos?

InflaRx (IFRX) não distribuiu dividendos no último ano.

Is InflaRx (IFRX) a good investment?

Atualmente, InflaRx (IFRX) está cotada a US$ 2.08, com um P/L de -4.08, representando um desvio de -219% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 54.85 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 54.85%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy InflaRx (IFRX) stock?

Investir em ações de InflaRx (IFRX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of InflaRx (IFRX) yield today?

A rentabilidade de InflaRx (IFRX) foi de -1.19% no último mês, 54.85% no último ano e -24.55% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de InflaRx (IFRX) hoje, o investimento total seria de US$ 207.50, com base na cotação atual de US$ 2.08.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 321.31
Em 5 anos: US$ 156.56
Em 10 anos: US$ 207.50

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

IFRX

InflaRx N.V.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment IFRX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING IFRX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT InflaRx

InflaRx N.V.

United States

19 years

2017

49

PROFIT X PRICE IFRX

Financial Results IFRX

IFRX cash flow

Asset, Revenue and Profit Growth - IFRX

IFRX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions